title: Gabapentin attenuates superior oblique myokymia.
abstract: OBJECTIVE
  To investigate therapeutic effects of oral gabapentin therapy on superior oblique myokymia.
  
  
  METHODS
  Observational case series with measurement of visual acuity and eye movements before, during, and after therapy.
  
  
  METHODS
  Two adult patients with superior oblique myokymia, refractory to other therapies, were treated with gabapentin orally after informed consent was obtained. Eye movements were measured using the magnetic search coil technique.
  
  
  RESULTS
  Superior oblique myokymia completely resolved after starting gabapentin.
  
  
  CONCLUSIONS
  Gabapentin may be an effective treatment for superior oblique myokymia; a double-blind study seems justified.
authors: Department of Neurology, Case Western Reserve University, Cleveland, Ohio, USA. robert.tomsak@uhhs.com
authors: Robert L
authors: RL
authors: Tomsak
authors: Gregory S
authors: GS
authors: Kosmorsky
authors: R John
authors: RJ
authors: Leigh
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D000284:Administration, Oral; D000328:Adult; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D004172:Diplopia / Q000188:drug therapy* / Q000209:etiology; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005133:Eye Movements; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D020432:Trochlear Nerve Diseases / Q000150:complications / Q000188:drug therapy*; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin